Andere Sprachen

07.05. UK's MHRA approves Dawnzera for treatment of familial chylomicronemia syndrome
01.05. Otsuka's Profit Jumps 15% in Q1
30.04. Otsuka : Financial Report 1Q FY2026
30.04. Otsuka : Business Results Data 1Q FY2026
30.04. Otsuka Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
21.04. Crowdstrike, Dicker Data, Otsuka Corporation Expand Distributor-Led Services for Falcon Platform in JAPAC
03.04. Annual Securities Report FY2025(PDF:1,148KB)
19.03. Nuovi acquisti nel portafoglio Asia-Pacifico
19.03. Veranderingen in de Zuidoost-Aziatische beleggingsportefeuille van MarketScreener
19.03. Cartera Asia-Pacífico: Últimas compras
19.03. New purchases in Asian portfolio
19.03. Nouveaux achats dans le portefeuille Investisseur Asie-Pacifique
25.02. Otsuka : Notice Of The 65th Annual General Meeting Of Shareholders
20.02. Otsuka Corporation Announces Resignation of Makiko Hamabe as Outside Director, Effective February 20, 2026
20.02. Otsuka : Notice Concerning Changes in Directors
20.02. Otsuka : Notice regarding the Resignation of Outside Director
20.02. Otsuka : Notice Concerning Amendments to the Articles of Incorporation
20.02. Otsuka : Notice Concerning Introduction of a Medium- to Long-Term Incentive Remuneration Plan for Directors
10.02. Business Results FY2025(PDF:1,885KB)
02.02. Otsuka : Financial Report FY2025
02.02. Otsuka : Business Results Data FY2025
02.02. Otsuka : Notice Concerning Dividends of Surplus
02.02. Otsuka Corporation Announces Dividend for the Fiscal Year Ended December 31, 2025, Payable on March 30, 2026
02.02. Otsuka Corporation Provides Consolidated Earnings Guidance for the Six Months Ending June 30, 2026 and Fiscal Year Ending December 31, 2026
02.02. Otsuka Corporation Provides Dividend Guidance for the Second Quarter End of Fiscal Year Ending March 31, 2026
Keine Ergebnisse zu dieser Suche